Ladenburg Thalmann Starts Acadia Pharmaceuticals (ACAD) at Buy

Article Stock Quotes (1) Comments (0)

Ladenburg Thalmann initiates coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with a Buy.

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $1.51 yesterday, with a 52 week range of $0.90-$3.09.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh
• StreetInsider.com Pre-Open Movers 5/15: (MFLR) (CHCI) (SPWR) Higher; (XONE) (DE) (P) Lower (more...)
• Imperial Capital Starts Erickson Air-Crane (EAC) at In-Line

Create E-mail Alert Related Categories

New Coverage

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?